Filter
1847
Filtered Results: 1847
Text search:
Kenya
Ministry
of
Health,
World
Health
Organization
(WHO)
Featured
Recommendations
146
New Publications
415
Language
Document type
No document type
982
Studies & Reports
396
Guidelines
189
Manuals
111
Strategic & Response Plan
80
Training Material
43
Situation Updates
20
Fact sheets
17
Resource Platforms
4
Infographics
2
Brochures
1
App
1
Online Courses
1
Countries / Regions
Kenya
289
Global
85
Uganda
82
Africa
58
Ethiopia
46
Nigeria
45
Malawi
36
Tanzania
36
Rwanda
35
Zambia
31
South Sudan
28
Congo, Democratic Republic of
27
Sierra Leone
20
East and Southern Africa
20
Ghana
19
Zimbabwe
19
South Africa
18
Liberia
18
Mozambique
17
India
17
Nepal
15
Lesotho
15
Namibia
15
Senegal
13
Guinea
12
West and Central Africa
11
Botswana
10
Cameroon
9
Bangladesh
9
Somalia
9
Madagascar
9
Syria
8
Ukraine
7
Burkina Faso
7
Western and Central Europe
7
Sudan
7
Myanmar / Burma
7
Eswatini/ Swaziland
7
Benin
6
South–East Asia Region
6
Indonesia
6
Pakistan
6
Cambodia
5
Asia
5
Central African Republic
5
Afghanistan
4
Latin America and the Carribbean
4
Middle East and North Africa
4
Eastern Europe
4
Russia
4
Yemen
4
Angola
4
Colombia
3
Thailand
3
Turkey
3
Togo
3
China
3
Iran
3
Philippines
3
Haiti
3
Jordan
3
Côte d’Ivoire / Ivory Coast
3
Sri Lanka
3
Chad
3
Tajikistan
2
Mexico
2
Gambia
2
Laos
2
Niger
2
Burundi
2
Eastern Europe and Central Asia
2
Southern Africa
2
Lebanon
2
Brazil
2
Mali
2
Iraq
2
North Macedonia
1
North Korea
1
Kazakhstan
1
Albania
1
Canada
1
Estonia
1
Peru
1
Vanuatu
1
Morocco
1
Guinea-Bissau
1
Germany
1
Saudi Arabia
1
Western Pacific Region
1
Gabon
1
Japan
1
Mauritius
1
Tunisia
1
Morocco
1
Argentina
1
Vietnam
1
Papua New Guinea
1
Djibouti
1
Greece
1
Palestine
1
Georgia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
699
Clinical Guidelines
121
Women & Child Health
108
Public Health
107
Key Resources
97
Capacity Building
45
Pharmacy & Technologies
13
Annual Report MEDBOX
1
Toolboxes
HIV
223
Mental Health
122
Disability
117
TB
98
COVID-19
94
AMR
71
Planetary Health
69
NTDs
69
Caregiver
57
Ebola & Marburg
37
Conflict
34
Rapid Response
30
Global Health Education
30
Refugee
29
Pharmacy
28
Health Financing Toolbox
28
Malaria
23
Natural Hazards
19
NCDs
18
2.0 Rapid Response
15
Cholera
12
Polio
8
Social Ethics
6
Zika
5
Specific Hazards
2
South Sudan
1
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
Strengthening global health security to protect the world against future epidemics and pandemics requires well-tested and decentralized capacities for the local detection and rapid containment of outbreaks of infectious disease. For such capacities to translate into effective response actions, ind...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on trends are also included. The limitations of low-birth-weight data are described and recommendations a...
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
Safe sanitation is essential for health, from preventing infections to improving and maintaining mental and social
well-being. Lack of adequate sanitation contributes to diarrhoeal diseases, parasitic infections, and undernutrition, as
well as posing significant risks and causing anxiety, especial...
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
Trachoma is the world’s leading infectious cause of blindness. It is one of 18 neglected
tropical diseases (NTDs) that affect over one billion of the world’s poorest people.
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
This practical document is available to support programmes and partners to design and implement risk communication strategies to achieve high uptake of malaria vaccination.
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex...
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during pregnan...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
2nd edition. The purpose of this document is to present updated standardized protocols that P. falciparum-endemic countries can use to determine the prevalence of parasites with pfhrp2/3 gene deletions causing negative HRP2 RDT results among symptomatic falciparum patients. The findings should be us...
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment.
